Categories AlphaGraphs, Earnings, Health Care

Abbott Laboratories (ABT) Q3 2024 Earnings: Key financials and quarterly highlights

Abbott Laboratories (NYSE: ABT) reported third quarter 2024 earnings results today.

Total reported sales increased 4.9% year-over-year to $10.6 billion. Organic sales growth was 7.6%.

Net earnings increased 14.6% to $1.64 billion, or $0.94 per share, compared to last year. Adjusted EPS rose 6.1% to $1.21.

Abbott expects GAAP EPS of $3.34-3.40 and adjusted EPS of $4.64-4.70 for full-year 2024. For the fourth quarter of 2024, the company expects GAAP EPS of $0.96-1.02 and adjusted EPS of $1.31-1.37.

Prior performance

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Important takeaways from Conagra Brands’ Q3 2025 report

Conagra Brands, Inc. (NYSE: CAG) has reported weaker-than-expected revenue and profit for the February quarter, with sales declining across all business segments amid softer demand and persistent supply challenges. The

Main takeaways from Lamb Weston’s (LW) Q3 2025 earnings report

Shares of Lamb Weston Holdings, Inc. (NYSE: LW) jumped 9% on Thursday after the company delivered better-than-expected results for the third quarter of 2025 and reaffirmed its outlook for the

Summary: Tesla (TSLA) reports Q1 2025 production, deliveries

Tesla Inc. (NASDAQ: TSLA) has announced results of vehicle production and deliveries for the first quarter of 2025. The company also provided data on the deployment of energy storage products

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close